HEPCDAC AND HEPCVIR TABLETS

Get a Price/Quote

HEPCDAC AND HEPCVIR TABLETS Specification

Indication
Chronic Hepatitis C infection

Origin of Medicine
India

Pacakaging (Quantity Per Box)
28 Tablets

Dosage Form
Tablet

Salt Composition
HEPCDAC: Sofosbuvir 400mg + Daclatasvir 60mg; HEPCVIR: Sofosbuvir 400mg + Velpatasvir 100mg

Drug Type
Allopathic

Ingredients
Sofosbuvir and Daclatasvir (HEPCDAC), Sofosbuvir and Velpatasvir (HEPCVIR)

Physical Form
Tablets

Function
Antiviral; inhibits HCV replication

Recommended For
Treatment of Hepatitis C Virus (HCV) infection

Dosage
As prescribed by physician

Dosage Guidelines
Take orally with or without food

Suitable For
Adults

Quantity
28 Tablets per box

Storage Instructions
Store in a cool and dry place, away from sunlight

HEPCDAC AND HEPCVIR TABLETS Trade Information

Packaging Details
PACK OF 20 TABLETS

Main Domestic Market
All India

About HEPCDAC AND HEPCVIR TABLETS

Hepcvir And Hepcdac

Hepcvir

specification:-

brand name - hepcvir
content- sofosbuvir 400 mg
form- tablets
packing - pack of 28 tablets
manufacturer by - cipla

Hepcdac

specification:-

brand name - hepdac
content - declatasvir
strength - 60 mg
form - tablets
packing - pack of 28 tablets
manufacturer by - cipla

Note:- Hepcvir And Hepcdac Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug........

Powerful Antiviral Therapy for Hepatitis C

HEPCDAC and HEPCVIR deliver a potent and targeted antiviral effect, disrupting HCV replication with a dual-drug combination. Their direct-acting mechanism offers a reliable solution for adults suffering from chronic Hepatitis C. Used globally and approved by health authorities, these medicines are recognized for their efficacy across Asia and Africa.

Simple and Convenient Administration

Both HEPCDAC and HEPCVIR come as film-coated tablets designed to be taken orally, either with or without food, ensuring user convenience. Their compact packaging of 28 tablets per box suits monthly dosage cycles, aiding seamless treatment adherence while allowing straightforward storage in cool, dry conditions.

Safety and Tolerability

These medications offer a well-documented safety profile with side effects that may include fatigue, headache, nausea, insomnia, and anemia. They are not recommended for pediatric use and must not be consumed by individuals hypersensitive to their components. Regular medical supervision ensures safe and effective use throughout the treatment course.

FAQs of HEPCDAC AND HEPCVIR TABLETS:

Q: How should I take HEPCDAC or HEPCVIR tablets for Hepatitis C?

A: Take the tablets orally as prescribed by your physician, once daily, with or without food. Consistency in timing helps maintain effective drug levels in the body.

Q: What are HEPCDAC and HEPCVIR indicated for?

A: These medicines are indicated for the treatment of chronic Hepatitis C infection in adults. They work by inhibiting the replication of the Hepatitis C Virus, which helps clear the infection.

Q: When should I avoid using HEPCDAC or HEPCVIR tablets?

A: Do not use these tablets if you have a known hypersensitivity to any of their ingredients or if you are a pediatric patient, as they are intended for adult use only.

Q: What should I do if I experience side effects like fatigue or headache while using these tablets?

A: Mild side effects such as fatigue or headache are not uncommon. However, if they persist or worsen, consult your healthcare provider for assessment and guidance.

Q: Where should I store HEPCDAC and HEPCVIR tablets?

A: Store the tablets in a cool, dry place away from sunlight to retain their effectiveness throughout their 24-month shelf life.

Q: Can HEPCDAC and HEPCVIR be used with other antiviral medicines?

A: Yes, these direct-acting antivirals can be combined with other antiviral agents if clinically recommended. Always follow your doctors advice regarding combination therapy.

Q: What are the benefits of using HEPCDAC and HEPCVIR for Hepatitis C?

A: These tablets offer proven efficacy in treating HCV infection, increasing the chances of achieving a sustained virologic response. International health authorities have approved them for adult use.

Tell us about your requirement